Zlotnik A, Yoshie O (2012) The chemokine superfamily revisited. Immunity 36(5):705–716. https://doi.org/10.1016/j.immuni.2012.05.008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luster AD (1998) Chemokines—chemotactic cytokines that mediate inflammation. N Engl J Med 338(7):436–445. https://doi.org/10.1056/NEJM199802123380706

Article  CAS  PubMed  Google Scholar 

Thelen M, Stein JV (2008) How chemokines invite leukocytes to dance. Nat Immunol 9(9):953–959. https://doi.org/10.1038/ni.f.207/1

Article  CAS  PubMed  Google Scholar 

Proost P, Struyf S, Van Damme J, Fiten P, Ugarte-Berzal E, Opdenakker G (2017) Chemokine isoforms and processing in inflammation and immunity. J Autoimmun 85:45–57. https://doi.org/10.1016/j.jaut.2017.06.009

Article  CAS  PubMed  Google Scholar 

Opdenakker G, Proost P, Van Damme J (2016) Microbiomic and posttranslational modifications as preludes to autoimmune diseases. Trends Mol Med 22(9):746–757. https://doi.org/10.1016/j.molmed.2016.07.002

Article  CAS  PubMed  Google Scholar 

Lee EY, Lee ZH, Song YW (2013) The interaction between CXCL10 and cytokines in chronic inflammatory arthritis. Autoimmun Rev 12(5):554–557. https://doi.org/10.1016/j.autrev.2012.10.001

Article  CAS  PubMed  Google Scholar 

Abron JD, Singh NP, Murphy AE, Mishra MK, Price RL, Nagarkatti M et al (2018) Differential role of CXCR3 in inflammation and colorectal cancer. Oncotarget 9(25):17928–17936. https://doi.org/10.18632/oncotarget.24730

Article  PubMed  PubMed Central  Google Scholar 

Kuo PT, Zeng Z, Salim N, Mattarollo S, Wells JW, Leggatt GR (2018) The role of CXCR3 and its chemokine ligands in skin disease and cancer. Front Med 5:271. https://doi.org/10.3389/fmed.2018.00271

Article  Google Scholar 

Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP (2005) CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 16(6):593–609. https://doi.org/10.1016/j.cytogfr.2005.04.007

Article  CAS  PubMed  Google Scholar 

Keeley EC, Mehrad B, Strieter RM (2011) Chemokines as mediators of tumor angiogenesis and neovascularization. Exp Cell Res 317(5):685–690. https://doi.org/10.1016/j.yexcr.2010.10.020

Article  CAS  PubMed  Google Scholar 

Wang J, Knaut H (2014) Chemokine signaling in development and disease. Dev 141(22):4199–4205. https://doi.org/10.1242/dev.101071

Article  CAS  Google Scholar 

Stein JV, Nombela-Arrieta C (2005) Chemokine control of lymphocyte trafficking: a general overview. Immunology 116(1):1–12. https://doi.org/10.1111/j.1365-2567.2005.02183.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen K, Bao Z, Tang P, Gong W, Yoshimura T, Wang JM (2018) Chemokines in homeostasis and diseases. Cell Mol Immunol 15(4):324–334. https://doi.org/10.1038/cmi.2017.134

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moser B, Wolf M, Walz A, Loetscher P (2004) Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25(2):75–84. https://doi.org/10.1016/j.it.2003.12.005

Article  CAS  PubMed  Google Scholar 

Gouwy M, Struyf S, Proost P, Van Damme J (2005) Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 16(6):561–580. https://doi.org/10.1016/j.cytogfr.2005.03.005

Article  CAS  PubMed  Google Scholar 

Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. J Cult Herit 1(2):121–127. https://doi.org/10.1016/s1074-7613(00)80165-x

Article  Google Scholar 

Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ et al (2014) International union of pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev 66(1):1–79. https://doi.org/10.1124/pr.113.007724

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bacon K, Baggiolini M, Broxmeyer H, Horuk R, Lindley I, Mantovani A et al (2003) Chemokine/chemokine receptor nomenclature. Cytokine 21(1):48–49. https://doi.org/10.1016/S1043-4666(02)00493-3

Article  CAS  Google Scholar 

Moelants EAV, Mortier A, Van Damme J, Proost P (2013) In vivo regulation of chemokine activity by post-translational modification. Immunol Cell Biol 91(6):402–407. https://doi.org/10.1038/icb.2013.16

Article  CAS  PubMed  Google Scholar 

Mortier A, Gouwy M, Van Damme J, Proost P (2011) Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Exp Cell Res 317(5):642–654. https://doi.org/10.1016/j.yexcr.2010.11.016

Article  CAS  PubMed  Google Scholar 

Mortier A, Van DJ, Proost P (2008) Regulation of chemokine activity by posttranslational modification. Pharmacol Ther 120(2):197–217. https://doi.org/10.1016/j.pharmthera.2008.08.006

Article  CAS  PubMed  Google Scholar 

Groom JR, Luster AD (2011) CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89(2):1–8. https://doi.org/10.1038/icb.2010.158.CXCR3

Article  Google Scholar 

Van Raemdonck K, Van den Steen PE, Liekens S, Van Damme J, Struyf S (2015) CXCR3 ligands in disease and therapy. Cytokine Growth Factor Rev 26(3):311–327. https://doi.org/10.1016/j.cytogfr.2014.11.009

Article  CAS  PubMed  Google Scholar 

Luster AD, Unkeless JC, Ravetch JV (1985) Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315(6021):672–676. https://doi.org/10.1038/315672a0

Article  CAS  PubMed  Google Scholar 

Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP et al (1998) Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187(12):2009–2021. https://doi.org/10.1084/jem.187.12.2009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee HH, Farber JM (1996) Localization of the gene for the human MIG cytokine on chromosome 4q21 adjacent to IP10 reveals a chemokine “mini-cluster.” Cytogenet Genome Res 74(4):255–258. https://doi.org/10.1159/000134428

Article  CAS  Google Scholar 

Tensen CP, Flier J, Van Der Raaij-Helmer EMH, Sampat-Sardjoepersad S, Van Der Schors RC, Leurs R et al (1999) Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J Invest Dermatol 112(5):716–722. https://doi.org/10.1046/j.1523-1747.1999.00581.x

Article  CAS  PubMed  Google Scholar 

Farber JM (1990) A macrophage mRNA selectively induced by γ-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci USA 87(14):5238–5242. https://doi.org/10.1073/pnas.87.14.5238

Article  CAS  PubMed  PubMed Central  Google Scholar 

Struyf S, Salogni L, Burdick MD, Vandercappellen J, Gouwy M, Noppen S et al (2011) Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. Blood 117(2):480–488. https://doi.org/10.1182/blood-2009-11-253591

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mueller A, Meiser A, McDonagh EM, Fox JM, Petit SJ, Xanthou G et al (2008) CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3. J Leukoc Biol 83(4):875–882. https://doi.org/10.1189/jlb.1006645

Article  CAS  PubMed  Google Scholar 

Farber JM (1997) Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61(3):246–257. https://doi.org/10.1002/jlb.61.3.246

Article  CAS  PubMed  Google Scholar 

Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I et al (1996) Chemokine Receptor Specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 184(3):963–969. https://doi.org/10.1084/jem.184.3.963

Article  CAS  PubMed  Google Scholar 

Campbell JJ, Qin S, Unutmaz D, Soler D, Murphy KE, Hodge MR et al (2001) Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 166(11):6477–6482. https://doi.org/10.4049/jimmunol.166.11.6477

Article  CAS  PubMed  Google Scholar 

Robertson MJ (2002) Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71(2):173–183. https://doi.org/10.1189/jlb.71.2.173

Article  CAS  PubMed  Google Scholar 

Taub DD, Sayers TJ, Carter CRD, Ortaldo JR (1995) Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 155:3877–3888

Article  CAS  PubMed  Google Scholar 

Inngjerdingen M, Damaj B, Maghazachi AA (2001) Expression and regulation of chemokine receptors in human natural killer cells. Blood 97(2):367–375. https://doi.org/10.1182/blood.v97.2.367